€37.1 B

Sanofi Revenue FY, 2015
Sanofi Revenue growth (FY, 2014 - FY, 2015), %10%
Sanofi Gross profit (FY, 2015)26.1 B
Sanofi Gross profit margin (FY, 2015), %70.5%
Sanofi Net income (FY, 2015)4.4 B

Sanofi Revenue

Sanofi revenue was €37.06 b in FY, 2015 which is a 9.7% year over year increase from the previous period.

Embed Graph

Sanofi Revenue Breakdown

Embed Graph

Sanofi revenue breakdown by business segment: 80.4% from Pharmaceuticals, 12.8% from Vaccines and 6.8% from Animal Health

Sanofi Income Statement

Annual

EURFY, 2013FY, 2014FY, 2015

Revenue

33.0b33.8b37.1b

Revenue growth, %

2%10%

Cost of goods sold

10.3b10.2b10.9b

Gross profit

22.6b23.5b26.1b

Gross profit Margin, %

69%70%71%

R&D expense

4.6b4.7b5.1b

General and administrative expense

8.0b8.4b9.4b

Operating expense total

12.6b13.1b14.5b

Depreciation and amortization

5.1b3.3b4.3b

Interest expense

609.0m598.0m559.0m

Interest income

111.0m192.0m178.0m

Income tax expense

726.0m(1.2b)(709.0m)

Net Income

3.9b4.5b4.4b

Sanofi Cash Flow

Annual

EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4b6.3b7.2b

Sanofi Ratios

EURY, 2015

Revenue/Employee

365.4k
Report incorrect company information

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA

1

Phase III Trials Products

11 9 8 7

Projects in R&D Pipeline

36 32 34 43
Report incorrect company information